Shanghai Record Pharmaceuticals co.,Ltd. was established in April 2003. It is a high-tech enterprise with strong research and development capabilities. It focuses on high value-added pharmaceutical intermediates, special fine chemical products in electronics and materials, and in recent years. The research, development and industrialization of API under the market license holder system (MAH), many of which are in a leading position in synthetic technologies and products. The products are mainly exported, and the market covers Europe, America, Japan, South Korea and other parts of the world. While becoming the main supplier of intermediates for internationally renowned pharmaceutical companies, it has established a good relationship with many Chinese and foreign chemical companies, foreign companies, and traders in the industry. Cooperative relationship. In addition, it is also preparing to build a production base for large quantities of fine chemical products in Quzhou, Zhejiang Province, which will effectively combine its own core technology to lay a solid foundation for expanding new business areas and product series in the future.